MDM2 and prostate cancer: For example, in a phosphatase and tension homolog (PTEN)-deficient prostate cancer model, IL-6-STAT3 signaling in tumor cells prevents tumor progression by maintaining a complete senescence-induced ARF-MDM2-p53 tumor suppressor axis [40].